openPR Logo
Press release

Demand for Antibody Testing Market is forecasted to reach a value of US$ 18.89 billion by 2034

02-07-2024 05:57 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Fact.MR

Demand for Antibody Testing Market is forecasted to reach a value

The antibody testing market is estimated to be valued at US$ 9.17 billion in 2024. The global demand for antibody testing products is projected to grow at a compound annual growth rate (CAGR) of 7.5%, reaching a market value of US$ 18.89 billion by the end of 2034.

Market Dynamics:

The antibody testing market is propelled by several key dynamics. Firstly, the rising incidence of infectious diseases, including COVID-19, HIV/AIDS, and hepatitis, has underscored the importance of efficient diagnostic tools for timely disease detection and management. Additionally, advancements in biotechnology have facilitated the development of innovative antibody testing platforms with enhanced sensitivity and specificity, fostering market expansion. Moreover, the growing demand for point-of-care testing (POCT) solutions and the increasing adoption of antibody testing in research and clinical settings further contribute to market growth.

For More Insights into the Market, Request a Sample of this Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=9194

Market Future Outlook:

The future outlook of the antibody testing market appears promising, with sustained growth anticipated in the coming years. Factors such as the continuous emergence of novel infectious diseases, the growing emphasis on personalized medicine, and the expanding applications of antibody testing in drug development are expected to drive market expansion. Furthermore, the integration of artificial intelligence (AI) and machine learning (ML) technologies into antibody testing platforms is poised to enhance diagnostic accuracy and efficiency, thereby bolstering market prospects. Additionally, the rising investments in healthcare infrastructure and the increasing healthcare expenditure in developing regions are likely to create lucrative opportunities for market players.

List of Key Companies Profiled in The Report

Thermos Fisher Scientific
Abbott Laboratories
Bio-Rad Laboratories, Inc.
F. Hoffmann La Roche
Beckton
Agilent Technologies
Dickinson and Company
DiaSorin
Trinity Biotech
Abcam
Zeus Scientific

Market Insights:

The antibody testing market encompasses various segments based on technology, application, end-user, and region. Enzyme-linked immunosorbent assay (ELISA), chemiluminescence immunoassay (CLIA), and lateral flow assays are among the widely adopted technologies for antibody testing. These tests find extensive applications in infectious disease diagnosis, autoimmune disease screening, oncology, and blood screening, among others. Hospitals and clinics, diagnostic laboratories, academic and research institutions, and pharmaceutical and biotechnology companies constitute the primary end-users of antibody testing products and services. Geographically, North America holds a significant share in the antibody testing market, attributed to the presence of well-established healthcare infrastructure, high healthcare expenditure, and the rapid adoption of advanced diagnostic technologies. However, the Asia-Pacific region is poised to witness substantial growth owing to the increasing disease burden, improving healthcare accessibility, and burgeoning investments in healthcare infrastructure.

Want Full Report? Enquire Here- https://www.factmr.com/report/antibody-testing-market

Recent Developments:

Suppliers of antibody testing products are embracing advanced technologies to innovate new equipment aimed at achieving more precise results. Additionally, industry players are committing resources to research and development endeavors to drive innovation, uphold product quality standards, optimize supply chain management systems, and foster collaborations.

For example, in July 2020, Cancer Research UK and Abcam Plc. joined forces to produce and market novel custom antibodies, showcasing the industry's commitment to collaborative efforts in advancing antibody testing capabilities.

Explore More Related Studies Published by Fact.MR Research:

Antibody Contract Manufacturing Market: https://www.factmr.com/report/antibody-contract-manufacturing-market

Antibody Drug Conjugates Contract Market: https://www.factmr.com/report/antibody-drug-conjugates-contract-market

Antibody Fragments Market: https://www.factmr.com/report/antibody-fragments-market

Contact:

US Sales Office

11140 Rockville Pike

Suite 400 Rockville, MD 20852

United States Tel: +1 (628) 251-1583, +353-1-4434-232 (D)

Sales Team: sales@factmr.com

About Fact.MR :

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Demand for Antibody Testing Market is forecasted to reach a value of US$ 18.89 billion by 2034 here

News-ID: 3376535 • Views:

More Releases from Fact.MR

Bioinformatics Market is Growing at a CAGR of 13.4% by 2034 | Fact.MR Report
Bioinformatics Market is Growing at a CAGR of 13.4% by 2034 | Fact.MR Report
The latest report on the Bioinformatics Market, projecting robust growth driven by the increasing demand for genomic research, advancements in artificial intelligence (AI), and the rising adoption of precision medicine. Valued at USD 14.29 billion in 2024, the global market is forecast to expand at a compound annual growth rate (CAGR) of 13.4%, reaching USD 50.25 billion by 2034. This significant growth underscores the critical role of bioinformatics in decoding
Residential Robotic Vacuum Cleaner Market to Reach USD 11.6 Billion by 2033 | Key Players: iRobot Corporation, Neato Robotics, Inc., Yujin Robot, Co., Ltd., and Dyson Inc
Residential Robotic Vacuum Cleaner Market to Reach USD 11.6 Billion by 2033 | Ke …
Fact.MR today released its latest report on the Residential Robotic Vacuum Cleaner Market, projecting robust growth driven by increasing demand for automation, busy lifestyles, and advancements in smart home technologies. Valued at USD 3.0 billion in 2023, the global market is forecast to expand at a compound annual growth rate (CAGR) of 14.4%, reaching USD 11.6 billion by 2033. This significant growth highlights the rising adoption of robotic vacuum cleaners
Brain-Computer Interface Market is Estimated to Reach USD 6.5 Billion by 2033
08-29-2025 | Health & Medicine
Fact.MR
Brain-Computer Interface Market is Estimated to Reach USD 6.5 Billion by 2033
The global brain-computer interface (BCI) market was valued at USD 1.6 billion in 2022 and is projected to reach USD 6.5 billion by 2033, growing at a compound annual growth rate (CAGR) of 13.6% from 2023 to 2033. This expansion reflects the increasing adoption of BCI technologies in medical applications, driven by advancements in neuroscience, AI, and sensor technologies. BCIs enable direct communication between the brain and external devices, offering
Orally Disintegrating Tablet Market is Projected to Reach USD 72.68 Billion by 2034 | Key Players: Johnson & Johnson Services Inc; Teva Pharmaceutical Industries Ltd.; Sun Pharmaceutical Industries Ltd.; Takeda Pharmaceutical Company Limited
08-29-2025 | Health & Medicine
Fact.MR
Orally Disintegrating Tablet Market is Projected to Reach USD 72.68 Billion by 2 …
The global orally disintegrating tablet (ODT) market is valued at USD 24.45 billion in 2024 and is forecasted to expand at a compound annual growth rate (CAGR) of 11.5%, reaching USD 72.68 billion by 2034. This robust growth is driven by the increasing demand for patient-friendly dosage forms, particularly among the elderly, pediatric, and dysphagic populations, who benefit from ODTs' ease of administration without water and rapid dissolution. ODTs enhance

All 5 Releases


More Releases for Antibody

Evolving Market Trends In The Antibody Drug Conjugates Industry: Regulation On A …
The Antibody Drug Conjugates Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Antibody Drug Conjugates Market Size During the Forecast Period? The market size for antibody drug conjugates has experienced rapid expansion in the past few years. It's projected to rise from
TIGIT Antibody Clinical Trials FDA Approval Market Size Anti TGIT Antibody Sales …
Anti TIGIT Antibodies Clinical Trials & Market Opportunity Outlook 2028 Report Highlights: • Anti TIGIT Antibodies In Clinical Trials: > 50 Antibodies • First Anti TIGIT Antibody To Get Approval Within Next 5 Years • Global Anti TIGIT Antibodies Clinical Pipeline Insight By Company, Indication and Phase • Insight On More Than 50 Anti TIGIT Antibodies In Clinical Trials • Anti TIGIT Antibodies Market Trends by Indication & Country • Global Anti TIGIT Antibodies Market Dynamics Download Report: https://www.kuickresearch.com/report-anti-tigit-antibody-anti-tigit-antibodies-fda-approved-tigit-antibody-tigit-inhibitors-tigit-drugs-approved-tigit-expression-tigit-ligand-tigit-gene In recent years, the global
Mammalian Polyclonal IgG Antibody Market, Mammalian Polyclonal IgG Antibody Mark …
"According to the research report, the global inspection machines market was valued at USD 845.21 million in 2022 and is expected to reach USD 1,437.59 million by 2032, to grow at a CAGR of 5.5% during the forecast period." Request Our Free Sample Report for Inspection Machines Market Insights and Emerging Trends @ https://www.polarismarketresearch.com/industry-analysis/inspection-machines-market/request-for-sample Report Overview Polaris Market Research, a leading global market research and consulting company, has recently published its latest report
Global Combination Antibody Therapy Market 2022: Antibody/Antibody Combination S …
The combination antibody therapy market is expected to experience significant growth in the coming years. Combination antibody therapy involves the use of two or more monoclonal antibodies (mAbs) in combination to treat various diseases, such as cancer, autoimmune disorders, and infectious diseases. Request For Free Sample Report of "Combination Antibody Therapy Market"@ https://www.persistencemarketresearch.com/samples/11740 Combination antibody therapy has several potential benefits over single-agent therapies, including increased efficacy, improved patient outcomes, and reduced toxicity.
Global Combination Antibody Therapy Market 2022: Antibody/Antibody Combination S …
Combination antibody therapy involves the use of two or more antibodies to target and treat a specific disease or condition. This type of therapy is often used in cancer treatment, as it can be more effective at targeting and killing cancer cells than single-antibody therapies. Combination antibody therapy can also be used to treat a range of other diseases and conditions, including autoimmune diseases, infectious diseases, and allergic conditions. Request For
Procalcitonin Antibody Market Report 2018: Segmentation by Type (Polyclonal Proc …
Global Procalcitonin Antibody market research report provides company profile for Ningbo Medicalsystem Biotechnology, Snibe, Vazyme Biotech, Getein Biotech, Hotgen Biotech, Lumigenex, Shanghai Medicine'nest Pharmaceutical, Thermo Fisher, Roche Diagnostics, bioMerieux, HyTest, Wondfo and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for